Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel RAB7A Mutation and Inhibited EGFR Degradation

Autor: Veronica Nisi, Franco Taroni, Cecilia Bucci, Tiziana Cavallaro, Maria De Luca, Giuseppe Lauria, Stefania Magri, James M. Polke, Roberta Romano, Davide Pareyson, Raffaella Lombardi, Giuseppe Piscosquito, Mary M. Reilly, Paola Fossa, Chiara Pisciotta, Elena Cichero, Gian Maria Fabrizi, Paola Saveri
Přispěvatelé: Saveri, P., De Luca, M., Nisi, V., Pisciotta, C., Romano, R., Piscosquito, G., Reilly, M. M., Polke, J. M., Cavallaro, T., Fabrizi, G. M., Fossa, P., Cichero, E., Lombardi, R., Lauria, G., Magri, S., Taroni, F., Pareyson, D., Bucci, C.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Proband
Male
Biopsy
Charcot Marie Tooth disease type 2B
Mutant
Peripherins
medicine.disease_cause
Ligands
Mice
CMT2B
Mutant protein
Charcot-Marie-Tooth Disease
RAB7
lcsh:QH301-705.5
Skin
axon
NGF
Mutation
Chronic axonal neuropathy
medicine.diagnostic_test
RAB7A
Charcot–Marie–Tooth disease type 2B
EGFR
autophagy
axons
endocytosis
lysosomes
mutations
neurite outgrowth
peripheral sensory neuropathy
Peripherin
General Medicine
Middle Aged
Pedigree
ErbB Receptors
endocytosi
Phenotype
RAB7A
Charcot Marie Tooth disease type 2B
CMT2B
peripheral sensory neuropathy
NGF
RAB7
mutations
axons
lysosomes
autophagy
neurite outgrowth
endocytosis
EGFR

lysosome
Female
Protein Binding
Adult
Adolescent
Neuronal Outgrowth
Biology
Article
Cell Line
medicine
Animals
Humans
Adaptor Proteins
Signal Transducing

Nerve biopsy
Base Sequence
Laminopathies
rab7 GTP-Binding Proteins
Fibroblasts
lcsh:Biology (General)
rab GTP-Binding Proteins
Proteolysis
Cancer research
Mutant Proteins
mutation
Zdroj: Cells
Cells, Vol 9, Iss 1028, p 1028 (2020)
Volume 9
Issue 4
Popis: The rare autosomal dominant Charcot-Marie-Tooth type 2B (CMT2B) is associated with mutations in the RAB7A gene, involved in the late endocytic pathway. CMT2B is characterized by predominant sensory loss, ulceromutilating features, with lesser-to-absent motor deficits. We characterized clinically and genetically a family harboring a novel pathogenic RAB7A variant and performed structural and functional analysis of the mutant protein. A 39-year-old woman presented with early-onset walking difficulties, progressive distal muscle wasting and weakness in lower limbs and only mild sensory signs. Electrophysiology demonstrated an axonal sensorimotor neuropathy. Nerve biopsy showed a chronic axonal neuropathy with moderate loss of all caliber myelinated fibers. Next-generation sequencing (NGS) technology revealed in the proband and in her similarly affected father the novel c.377A>
G (p.K126R) heterozygous variant predicted to be deleterious. The mutation affects the biochemical properties of RAB7 GTPase, causes altered interaction with peripherin, and inhibition of neurite outgrowth, as for previously reported CMT2B mutants. However, it also shows differences, particularly in the epidermal growth factor receptor degradation process. Altogether, our findings indicate that this RAB7A variant is pathogenic and widens the phenotypic spectrum of CMT2B to include predominantly motor CMT2. Alteration of the receptor degradation process might explain the different clinical presentations in this family.
Databáze: OpenAIRE